Indapta Therapeutics

1 Follower


Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.


Add photos to showcase Indapta Therapeutics’s culture


Add Indapta Therapeutics’s values

Insider experiences

Share your experience of working at Indapta Therapeutics

Guy DiPierro
CEO & Founder
Robert Sikorski
Chief Medical Officer
Lori Kunkel
Head Strategic Clinical Advisor
Austin Bigley
Senior Director, Research & Development
Catherine Polizzi
Chief Intellectual Property Counsel, Morrison & Foerster
Lisa Fox Craig
Head, Manufacturing & CMC
Kathy Leach
Manufacturing Advisor
Elana Van Oudenaren
Head, Quality
Nancy Weil
Head, Program Management

Add your teams to show how people work together at Indapta Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.